The complications of controlling agency time discretion: FDA review deadlines and postmarket drug safety
{{output}}
Public agencies have discretion on the time domain, and politicians deploy numerous policy instruments to constrain it. Yet little is known about how administrative procedures that affect timing also affect the quality of agency decisions. We examine whether a... ...
